Alpha‑fetoprotein (AFP) is a tumour marker measured in blood that can assist in detecting and monitoring certain cancers. AFP may be elevated in malignancies such as testicular non‑seminomatous germ‑cell tumours, hepatocellular carcinoma (HCC), and hepatoblastoma. Levels may also be increased in benign liver conditions or during pregnancy, limiting its specificity. AFP is used mainly in hospital settings and is most valuable for monitoring disease progression or response to treatment rather than for screening.
Alpha-fetoprotein
High AFP
High AFP levels can occur in several malignancies, particularly testicular non seminomatous germ cell tumours, hepatocellular carcinoma (HCC), and hepatoblastoma. AFP can also be elevated in some benign liver diseases and during pregnancy, limiting its specificity. Therefore, a high AFP result supports but does not by itself diagnose malignancy; it is most useful for monitoring staging, progression, or response to treatment.
Low or Normal AFP
A normal or low AFP level does not rule out cancer, as tumour markers lack sensitivity and may remain normal in early stage or even advanced disease. Thus, AFP must be interpreted alongside imaging, clinical findings, and other investigations.
Case Study
Delivering True Innovation
Our Services
Venous serum 5ml
Result Values
Quantitative results for AFP are reported in numeric value in ng/ml Please contact us for more information on the reference ranges used at Enfer Medical.
Patient
Request Form
For clients using the Enfer Medical Client Portal, the Enfer Medical Patient Request Form (PRF) will be generated when you have completed your “Test Request” within the portal linked below.
Please note that samples suspected of containing high risk pathogens such as Mycobacterium tuberculosis should be clearly identified on the form and packed separately from other samples.
Results are available next working day.
This assay is available seven days a week.
Packaging
The packaging/preparation of samples for delivery to the laboratory are required to be in adherence to all national regulations for the safe transport of biological materials. HSE guidance can be reviewed HERE.
There are specific packaging instructions and labelling requirements requiring triple packaging including:
- Primary leak-proof container – tube or vial containing the sample.
- Secondary watertight container, with absorbent material, intended to protect the primary container.
- Outer container protects the secondary container.
- Patient Request forms must be placed between the secondary container and the outer shipping container.
Further information on the packaging/preparation of samples for delivery to the laboratory is contained within the Enfer Medical Laboratory User Manual which clients are provided with.
Storage & Stability
Specimens must be tested within 7 days of collection and stored at 2-8°C.
Samples
In addition to the packaging of samples, the transport/delivery of clinical samples to the laboratory is required to be in adherence to all national regulations for the safe transport of biological materials. Enfer Medical provides a fully compliant logistics service, aligned with clients’ testing requirements.
Prompt transport of specimens:
To ensure prompt testing of samples and release of results within the published test turnaround times, samples should arrive to the laboratory by 18:00. Test turnaround time is measured from receipt of the sample at the laboratory until the time the authorised results are reported to users.
of Samples
In rare cases specimens may not be suitable for testing on arrival to the laboratory. In that case the sample will be rejected at the receipt stage and the service user will be notified immediately and an explanation as to why the sample could not be processed will be provided. Reasons why samples cannot be processed include but are not limited to:
- Samples received beyond the stability limits and/or not at the correct temperature indicated for each test.
- Incorrect sample type received.
- Leaking samples, sample not received or sample insufficient for analysis as stated below within sample requirements.
- Non-compliant samples or request forms i.e. those missing sample date information, missing sample test request and/or missing sample site/type information.
- Samples received without the necessary patient identifiers.
Our Services
Accessing
Your Results
Following receipt at the laboratory, results should be available on the next working day and will be reported to the referring clinician via the Enfer Medical Client Portal or in a format agreed with clients.
Established clients can login to the portal using the link above.